
Tarsus Pharmaceuticals, Inc.
Tarsus Pharmaceuticals, Inc.(TARS)股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
tars · 股价预测 · 9 位分析师(近3月)· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 9 位华尔街分析师
Buy
9 位分析师
共识
评级分布
12 个月目标价
High
$100
Consensus
$84.00
+40.2% upside
Low
$68.00
Median: $84 · Last Close: $59.92
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$84.00
40.2% upside
High Target
$100
66.9%
Low Target
$68
13.5%
Current Price
$59.92
as of today
Based on analyst price targets, the TARS stock price prediction for the next 12 months ranges from $68 to $100. The consensus TARS price forecast of $84.00 implies 40.2% upside from the current price of $59.92.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $58.67 | ↓ 2.10% |
1-day model range: $58.37–$58.96. Peak: $58.96 (-2.10%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $99 | +65.1% |
| 2028 | $138 | +129.6% |
| 2029 | $170 | +183.4% |
| 2030 | $194 | +223.3% |
| 2031 | — | +250.6% |
基于技术分析的股价预测
14 项技术面信号(SMA×6 + EMA×6 + RSI + MACD)· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · TARS · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-25 | Oppenheimer | Maintains | Outperform→Outperform |
| 2026-02-25 | Guggenheim | Maintains | Buy→Buy |
| 2025-11-05 | Guggenheim | Maintains | Buy→Buy |
| 2025-10-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-05-05 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-05-02 | Guggenheim | Maintains | Buy→Buy |
| 2025-03-06 | Jefferies | Maintains | Buy→Buy |
| 2025-02-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-26 | Barclays | Maintains | Overweight→Overweight |
Wall Street analysts have recently issued updated ratings on Tarsus Pharmaceuticals, Inc. (TARS) stock. Of the recent 45 rating actions, 0 were upgrades and 1 were downgrades. 9 analysts currently cover TARS.
分析师推荐趋势
TARS analyst recommendation trends show stable buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 1 per month.
财务预测:EPS 与营收一致预期
Revenue This Year
$696M
↓ 36.1% YoY
Revenue Next Year
$905M
↑ 29.9% YoY
EPS This Year
$-0.62
EPS Next Year
$3.03
↓ 590.1% YoY
EPS ForecastReported vs Estimated
Analysts forecast TARS EPS of $-0.62 for the current fiscal year, based on estimates from 6 analysts. The TARS revenue forecast is $696M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
TARS 股价预测由两类独立数据源支撑:来自 9 位华尔街分析师(S&P Global / FMP)的共识评级,以及基于历史日终价计算的技术分析。TARS 的共识目标价为 $84.00(+40.2% 上行空间),分析师共识为 Buy。
TARS 的短期预测(明日)为 $58.67(-2.10%)。 TARS 对 2027 年的股价预测均值为 $99。 TARS 对 2030 年的预测区间为 $183–$204。
Tarsus Pharmaceuticals, Inc. 在 NASDAQ 上市,代码 TARS。TARS 在 2027 年的整体展望偏积极,在覆盖分析师中约 89% 对应 Buy 共识。
常见问题
TARS 预测 · 8 个问题根据 9 位华尔街分析师,TARS 的 12 个月平均目标价为 $84.00,最高 $100.00、最低 $68.00。若有图表,中位目标价可在上方查看。相对当前价 $59.92,隐含约 +40.2% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.